Abstract: An osmotic dispensing device is disclosed for delivering a medicine to a biological environment of use. The device comprises a semipermeable wall surrounding a compartment with an osmotic passageway in the semipermeable wall connecting the outside of the device with the compartment. The compartment houses a medicine releasable carrier by a means for increasing in size for delivering the beneficial medicine from the device over time.
Abstract: A dispensing device is disclosed for delivering a beneficial agent. The device comprises (1) a housing defining an internal space, (2) heat responsive means containing a beneficial agent in the space, (3) means for increasing the amount of beneficial agent delivered from the device in the space, (4) expandable means in the space, (5) an optional dense means in the space, and (6) means in the housing for delivering the beneficial agent from the dispensing device.
Type:
Grant
Filed:
August 9, 1985
Date of Patent:
November 25, 1986
Assignee:
ALZA Corporation
Inventors:
James B. Eckenhoff, Richard Cortese, Felix A. Landrau
Abstract: A self-contained body mounted pump assembly for continuously administering a therapeutic agent parenterally. The pump has a transparent top through which the contents can be seen and outwardly flaring sides to provide for comfort, stability and other useful features. The pump assembly is driven by a fluid imbibing, preferably osmotic pump and contains its own source of actuating fluid. Means for superimposing a pulse dose on the tonic flow are also described.
Type:
Grant
Filed:
August 19, 1985
Date of Patent:
October 28, 1986
Assignee:
ALZA Corporation
Inventors:
James B. Eckenhoff, John R. Peery, Felix A. Landrau
Abstract: An osmotic device is disclosed for delivering a beneficial agent formulation to the stomach and small intestine. The device delivers substantially all of the beneficial agent in the stomach and small intestine, collapses and is easily eliminated from a host.
Type:
Grant
Filed:
March 23, 1984
Date of Patent:
October 7, 1986
Assignee:
ALZA Corporation
Inventors:
George V. Guittard, Patrick S. L. Wong, Felix Theeuwes
Abstract: A high flux transdermal nitroglycerin therapeutic system is disclosed which is capable of delivering nitroglycerin through intact human skin at rates of 40 .mu.g/cm.sup.2 hr and preferably in the range of 50-150 .mu.g/cm.sup.2 hr. Ethanol delivered at a rate of from 250-500 .mu.g/cm.sup.2 hr is employed as a permeation enhancer for the nitroglycerin and a rate controlling membrane formed from ethylene vinyl acetate having a vinyl acetate content greater than 11% and preferably between 12-18% provides the appropriate rate control for both the drug and the permeation enhancer. This system is suitable for use in treatment of angina pectoris and congestive heart failure.
Abstract: An osmotic system is disclosed comprising a wall formed in at least a part of a semipermeable material that surrounds a compartment. The compartment contains a first osmotic composition comprising a beneficial agent, and a second and different osmotic composition. A passageway in the wall connects the first composition with the exterior of the system.
Type:
Grant
Filed:
December 21, 1984
Date of Patent:
September 16, 1986
Assignee:
Alza Corporation
Inventors:
Patrick S. L. Wong, Brian Barclay, Joseph C. Deters, Felix Theeuwes
Abstract: A dispensing device is disclosed for delivering a beneficial agent. The device comprises (1) a semipermeable housing defining an internal space, (2) a dense member in the space, (3) a heat responsive composition containing a beneficial agent in the space, (4) an expandable member in the space, and (5) a passageway in the semipermeable housing for delivering the beneficial agent from the dispensing device.
Type:
Grant
Filed:
September 27, 1985
Date of Patent:
September 16, 1986
Assignee:
ALZA Corporation
Inventors:
James B. Eckenhoff, Richard Cortese, Felix A. Landrau
Abstract: An osmotic dispensing device is disclosed for delivering a medicine to a biological environment of use. The device comprises a semipermeable wall surrounding a compartment with an osmotic passageway in the semipermeable wall connecting the outside of the device with the compartment. The compartment house a medicine releasably held on a carrier member selected from the group consisting of cellulose esters, cellulose ethers and cellulose ester-ethers.
Abstract: An osmotic device is disclosed for delivering an agent to a selected environment. The device comprises a semipermeable wall surrounding a first and second compartment for containing the agent, and the device is provided with means for delivering the agent from both compartments through a single osmotic passageway.
Abstract: A patient-care system is disclosed comprising a container housing a device that delivers an agent for controlling the presence of pathogens. Also, the device and a method are disclosed using the device for preventing pathogenic infections.
Type:
Grant
Filed:
April 11, 1985
Date of Patent:
July 22, 1986
Assignee:
ALZA Corporation
Inventors:
Patrick S. L. Wong, Jimmy B. Langston, Harold M. Leeper
Abstract: A formulation cell consisting essentially of a hollow fiber surrounded by a beneficial agent is disclosed for use in an intravenous delivery system. An intravenous system is disclosed that uses the formulation cell.
Abstract: A dispensing device is disclosed for delivering a beneficial agent. The device comprises (1) a semipermeable housing defining an internal space, (2) a dense member in the space, (3) a heat responsive composition containing a beneficial agent in the space, (4) an expandable member in the space, and (5) a passageway in the semipermeable housing for delivering the beneficial agent from the dispensing device.
Type:
Grant
Filed:
March 19, 1984
Date of Patent:
June 17, 1986
Assignee:
ALZA Corporation
Inventors:
James B. Eckenhoff, Richard Cortese, Felix A. Landrau
Abstract: End burning gas generators for use either as propulsion systems or means for generating large volume of gases for various purposes such as the generation of the fuel for a ducted rocket engine, the rapid inflation of air bags for personal protection or recovery of submersed items or the expulsion of projectiles from subsurface launch tubes are currently widely utilized. End burning gas generator grains are ignited at one end of a generally cylindrical charge mounted within a combustion chamber which is fixed with a suitable exhaust means. For many of the applications described above, it is desirable that the gas generator burn in a uniform manner such that a constant volume of gas is generated per unit of time so that the chamber pressure and the mass flow rate of gas remain constant.
Abstract: Transdermal delivery systems for delivery of fentanyl and its analgetically effective derivatives for extended periods of time are disclosed which deliver the base form of the drug at a rate of from 0.5 to 10 .mu.g/cm.sup.2 /hr for a substantial portion of their useful life. The systems can be from 5-100 cm.sup.2 in releasing surface and preferably employ an in-line amine resistant adhesive. Preferred rate controlled systems utilize an aqueous ethanolic gel to minimize drug content.
Type:
Grant
Filed:
July 23, 1984
Date of Patent:
May 13, 1986
Assignee:
Alza Corporation
Inventors:
Robert M. Gale, Victor Goetz, Eun S. Lee, Lina T. Taskovich, Su I. Yum
Abstract: An osmotic device is disclosed for delivering a beneficial agent to a first environment having a pH of 1.0 to 3.5 inclusive and to a second environment having a pH of greater than 3.5 to 8.0. The device maintains its integrity in the first environment and loses its integrity in the second environment.
Type:
Grant
Filed:
January 22, 1985
Date of Patent:
May 6, 1986
Assignee:
Alza Corporation
Inventors:
David Edgren, Patrick S. L. Wong, Felix Theeuwes
Abstract: A formulation chamber is disclosed comprising a wall surrounding a lumen containing a device for delivering a beneficial agent. The chamber has an inlet for admitting a fluid into the chamber and an outlet for letting an agent formulation leave the chamber. The chamber is adapted for use in an intravenous delivery system for delivering an agent formulation to a patient.
Abstract: A parenteral delivery set is disclosed for administering a beneficial agent to a recipient. The set comprises (a) a primary container of a medical fluid; (b) a primary tubing in fluid communication with the primary container; (c) a secondary container of a medical fluid; (d) a secondary tubing in fluid communication with the secondary container; (e) a formulation chamber connected to the secondary tubing and housing an agent dispensing device or the beneficial agent; and (f) a common tubing in communication with the primary tubing and the secondary tubing for communicating the set to the recipient.
Abstract: A delivery system is disclosed comprising a wall surrounding a lumen containing a plurality of osmotic delivery devices. The wall is formed of an environment sensitive material that releases the tiny osmotic devices into the environment. The osmotic devices comprise a semipermeable wall surrounding a compartment containing drug. A passageway through the semipermeable wall releases drug from the device to the environment.